FOR THE NEXT GENERATION OF PHYSICIANS
← All USMLE guides
CARDIOVASCULAR SYSTEM

Dyslipidemia and statins: who to treat and which drug.

Statins, ezetimibe, fibrates, niacin and PCSK9 inhibitors: mechanism, side effects and which patients need which on USMLE.

Lipid questions pair a drug with its mechanism and its signature adverse effect. Statins come first for almost every indication.

Drugs and mechanisms

  • Statins block HMG-CoA reductase; risk of myopathy and raised liver enzymes.
  • Ezetimibe blocks cholesterol absorption at the intestinal border.
  • Fibrates activate PPAR-alpha and lower triglycerides; risk of gallstones and myopathy with statins.
  • Niacin lowers LDL and triglycerides and raises HDL; causes flushing, treated with aspirin.
  • PCSK9 inhibitors increase LDL receptors.
  • Bile acid resins can raise triglycerides.

Who gets a statin

Established atherosclerotic disease, LDL of 190 mg/dL or more, diabetes aged 40 to 75, and adults with a high estimated 10-year risk. Intensity depends on risk.

Familial disorders

Familial hypercholesterolemia is an LDL receptor defect with tendon xanthomas and early coronary disease. Severe hypertriglyceridemia above about 1000 mg/dL risks pancreatitis.

Keep going in cardiovascular system

Related on USMLE WEB

Frequently asked questions

What is the signature statin side effect?

Myopathy, with raised creatine kinase in severe cases.

Which drug causes flushing?

Niacin, prostaglandin-mediated.